HEALTH NEWS

Study Title:

Fisetin Acts on Multiple Pathways to Reduce the Impact of Age and Disease on CNS Function

Study Abstract

It is becoming increasingly clear that neurological diseases are multi-factorial involving disruptions in multiple cellular systems. Thus, while each disease has its own initiating mechanisms and pathologies, certain common pathways appear to be involved in most, if not all, neurological diseases described to date. Thus, it is unlikely that modulating only a single factor will be effective at either preventing disease development or slowing disease progression. A better approach is to identify small (< 900 daltons) molecules that have multiple biological activities relevant to the maintenance of brain function. Over the last few years, we have identified an orally active, novel neuroprotective and cognition-enhancing molecule, the flavonoid fisetin. Fisetin not only has direct antioxidant activity but it can also increase the intracellular levels of glutathione, the major intracellular antioxidant. Fisetin can also activate key neurotrophic factor signaling pathways. In addition, it has anti-inflammatory activity against microglial cells and inhibits the activity of lipoxygenases, thereby reducing the production of pro-inflammatory eicosanoids and their by-products. This wide range of actions suggests that fisetin has the ability to reduce the impact of age-related neurological diseases on brain function.
Keywords: oxidative stress, glutathione, neurotrophic factors, memory, microglia, inflammation

Study Information

Front Biosci (Schol Ed). Author manuscript; available in PMC 2017 Jul 26. Published in final edited form as: Front Biosci (Schol Ed). 2015 Jun 1; 7: 58–82. Published online 2015 Jun 1.

Full Study

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527824/